Andrea Cortegiani
@AndCorteg
Followers
381
Following
1K
Media
17
Statuses
231
Sicilian Anesthesiologist and Intensivist. Associated Professor @unipa_it. 🤔Very Normal Person, Amateur Daddy, Definitely Amateur Clinician Scientist
Palermo, Sicilia
Joined January 2016
@IM_Crit_ There is NO maximum dose to norepinephrine…I have saved a life (from deadly sustained release verapamil overdose) with 3 mcg/kg/min (yes 3 not 0.3; requiring pharmacist continuously preparing quadruple concentrated norepinephrine for hours…)
5
20
199
Great ‘Meet the expert’ by @MarcSamama at #ICARE2023 about coagulopathy and hemostasis in trauma. Disrupting dogmas and useful insights for clinical practice @Nadiadoc2410 @Siaarti_online
0
7
20
A honour to moderate with @AndCorteg the exceptional “Meet the Expert Session” led by #RobertTinoGrief How to improve the response to intra-Hospital CA #ICARE2023
@Siaarti_Online
1
5
11
@AndCorteg explains how human factors (fatigue 😴 especially) can impact patients outcome in ICU at #LIVES2023. ⚠️human factors is an evidence based science ➕➕➕ @DrMCecconi @ESICM
2
7
9
Can the use of non invasive continuous blood pressure monitoring reduce the risk of post operative organ injury? Join @unimessina and @Siaarti_online in niMON trial and help us to answer this question! #bloodpressure #volumeclamp #noninvasive #siaarti #unime
1
2
6
Hyperoxia in critically ill patients with sepsis and septic shock CCR Journal Watch https://t.co/Sp06oA6IDG
0
45
117
Worrisome #Anesthesiologists opinion on perioperative🌙 #nighttime work: 👉Increased risk for patients 👉Lower performance 👉 No education or training 👉 Impact on personal life 👉 Bad working condition. Thanks to 6000 #anesthesiologist @ESAIC_org #EJA
https://t.co/KvN05tPV7v
0
4
13
✅Empiric treatment of patients with sepsis and septic shock 🦠and place in therapy of cefiderocol 💊 ➡️ https://t.co/uYdhGZur88
#sepsis #septicshock #FOAMcc #FOAMed @jaacc_online @Siaarti_online #therapy
@AndCorteg @MariachiaraIpp1 @maxdulac @AGSIAARTI2022
0
4
4
Among patients with COVID-19 pneumonia and mild hypoxaemia, the use of High-flow nasal oxygen (HFNO) did not significantly reduce the likelihood of escalation of respiratory support. https://t.co/ZU2LhbUH09
5
21
46
Time to speak up about our conditions of night time work as Anaesthesiologists and on our opinion on patient risk and our well-being. Take credit of your contribution on this @ESAIC_org Survey: Night time work of Anaesthesiologists
esaic.activehosted.com
Together for patient safety...
0
1
1
The @BJAJournals celebrates a 20% increase in Citescore, a new @ElsevierConnect metric for journal performance. We are #1 in the category Anesthesiology & Pain Medicine! 🙏 More info: https://t.co/FFnZ6SrmOH
@HughHemmings @ELS_Anesthes @DaveGLambert @MrfStruys @Prof_HelenG
0
4
22
50% of intubated patients with #COVIDー19 may develop ventilator-associated pneumonia. Mortality of COVID-19 patients with VAP is nearly 45%. 3-time higher odds of developing VAP than no #COVIDー19 patients https://t.co/gBeK1d9Nid
@MariachiaraIpp1 @antibioticsmdpi #CriticalCare
pubmed.ncbi.nlm.nih.gov
The aim of this systematic review and meta-analysis was to estimate the pooled occurrence of ventilator-associated pneumonia (VAP) among patients admitted to an intensive care unit with COVID-19 and...
3
0
1
High flow nasal therapy vs. conventional oxygen therapy in COVID-19: 25 patients already randomized in the #COVIDHIGH trial! Interested in joining this multicentre randomized trial? Contact us or click on the link @Crimillina #COVIDー19 https://t.co/tQTIZPwEYN
0
3
3
#CritCare OpenAccess High flow #nasal_therapy vs #noninvasive #ventilation in #COPD
https://t.co/JhqGjabrXK
#FOAMed #FOAMcc #BMC #HFNT #AECOPD #respiratory_failure @jlvincen @ISICEM
1
26
54
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial https://t.co/wrwhl53Ivm
#ambulancejournal rss feeds #feedly
link.springer.com
Critical Care - The efficacy and safety of high flow nasal therapy (HFNT) in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease (AECOPD) are unclear. Our aim was...
0
1
1
Delighted to share our latest multicentre RCT published in @Crit_Care! High flow nasal therapy was not inferior to NIV in decreasing CO2 as initial ventilatory strategy in COPD exacerbation. Great teamwork! @Crimillina @StefanoNava5
#HFNT #NIV
https://t.co/6QBau5DKhn
link.springer.com
Critical Care - The efficacy and safety of high flow nasal therapy (HFNT) in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease (AECOPD) are unclear. Our aim was...
2
7
20
Predatory journals enter biomedical databases through public funding. Important organizations and institutions are involved. Important analysis shedding light on this phenomenon just published in the @bmj_company
#Predatory #ResearchEthics @dmoher
https://t.co/YUSacNrGV3
bmj.com
Providing guidance to publicly funded authors on how to publish their work in open access journals is likely to reduce the waste of public money, say David Moher and colleagues In the past decade the...
0
4
4
The @BJAJournals bringing you a free collection of curated review articles published in 2020 including on #anaesthesia #CriticalCare #pain #pharmacology #Delirium #patientsafety #COVID19 #medicaleducation #neuroscience #sustainability
The @BJAJournals presents the year 2⃣0⃣2⃣0⃣ in a special collection of review articles. Curious? Visit https://t.co/mrSNMqZmfK
@ELS_Anesthes @RCoANews @HughHemmings @AcklandLab @jghardman26 @avidan_michael @B_XTA @tony_absalom @rupert_pearse @LesleyColvin1
0
9
19
Great presentations by @JennieH31968241 @katy_skier @AndCorteg @lisarongmd on how to write and review manuscripts with some valuable nuggets...highly recommended!
The @RCoANews and @BJAJournals webinar is now online! RCoA and BJA webinar: Tough Decisions: How Editors Decide Which Papers to Publish @HughHemmings @JennieH31968241 @katy_skier @AndCorteg @lisarongmd
https://t.co/ALYB162oz0
0
6
11
Very pleased to have shared this talk on severe CAP with @JanJDeWaele. Right pathway of care, rapid diagnostics, consider risk factors for MDR when choosing antibiotics, carefull use of biomarkes, steroids not for all.
How to treat severe CAP by constructive discussion with A. Cortegiani and J. De Waele at @Smart_Meeting_M . Is there clear hyperinflammatory state at CAP? Biomarkers: carefully considered / Steroids: not for every patient with CAP. #esmart2020
0
5
8